Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmic, vitamins, minerals, dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, and analgesics; and anti-oxidants, balanced energy and protein drinks, and vitamins and nutraceuticals, as well as various active pharmaceutical ingredients. It provides its products under the Zifi, Zefu, Zocon, Amodep-AT, Zathrin, Mycoderm, Zoxan, Cotaryl, Pyrimon DF, Zipod, Vitcofol, Ziglim, Ziglim Plus 2, Electral, and Enerzal brand names. The company was founded in 1936 and is headquartered in Mumbai, India.

Revenue projections:

Revenue projections for FDC
Revenue projections for FDC



Financial Ratios:

currentRatio 3.01100
forwardPE 0.00000
debtToEquity 0.92800
earningsGrowth -0.16200
revenueGrowth 0.06500
grossMargins 0.65074
operatingMargins 0.07811
trailingEps 16.39000
forwardEps 23.30000

FDC Limited's current ratio of 3.011 means the company has enough liquidity to meet its short-term debt obligations. With sufficient cash reserves and current assets, FDC Limited can comfortably cover its liabilities, reflecting a strong financial outlook.
FDC's low growth in both earnings and revenue signals a potential profit decline. This could be a sign of financial trouble, suggesting that the company's profitability might shrink in the near future.
FDC's negative gross and operating margins suggest that the company is currently losing money, unable to generate profit from production or operations. This could signal inefficiencies in cost control or a drop in sales.
FDC's forward EPS exceeding its trailing EPS means that the company is expected to increase profitability in the current financial year. This reflects improved earnings potential, signaling that FDC is likely to outperform its previous year's financial performance.

Recommendation changes over time:

Recommendations trend for FDC
Recommendations trend for FDC


FDC has been receiving a buy bias from analysts, indicating confidence in its investment potential. This could drive more investors to view FDC as a reliable choice for their money, offering a promising avenue for future growth and financial gains.